A literature search provides supporting evidence. Rampton's review2 detailed case reports of small bowel ulcers, perforations, bleeding, strictures and reperforations following ingestion of NSAIDs. It is also noted that infants treated with indomethacin for patent ductus arteriosus have an increased incidence of-perforation and necrotizing enterocolitis2. A large epidemiological study found that patients taking NSAIDs had a 2.6 times increased risk of perforation and haemorrhage3. Studies'5 had shown that subjects taking NSAIDs, whether healthy volunteers or patients with rheumatoid or osteoarthritis, have increased intestinal permeability to 51Cr EDTA. Indomethacin suppositories had a similar effect, suggesting a systemic action. '11Indium labelled leucocyte scintigrams showed there was 'intestinal inflammation' with concomitant increased faecal excretion of the isotope. The main site affected is the small bowel. Radiological contrast studies in some patients demonstrated small bowel ulceration and strictures5.
Similar small bowel mucosal ulcers have been reported in patients with gastrointestinal bleeding6 but we have failed to find similar cases with perforations. However, rats given indomethacin developed similar ulcers in the distal small bowel7, some of which went on to perforation. It might be revealing to examine the distal small bowel ofNSAIDs users endoscopically.
As regards ill patients with haemorrhagic cystitis, bladder irrigation with 1% alum solution is worth trying8. There is no doubt that this saved our patient's life. Baclofen (Lioresal) is frequently used in the treatment of spasticity. It acts principally at a spinal level to reduce muscle tone'. Gamma aminobutyric acid (GABA) agonists are generally thought to be antiepileptic, although manufacturers recommend caution in using baclofen in patients with known epilepsy and also avoiding abrupt withdrawal2. Epilepsy has been reported 7 h after baclofen overdosagel. This is the first reported case of status epilepticus caused by therapeutic doses of baclofen in a patient previously free of epilepsy.
Case report
A 35-year-old woman was admitted via the accident and emergency department in May 1987. She had been born prematurely in 1952 and had received high concentrations of oxygen which produced retrolental fibroplasia. In February 1984 she was prescribed baclofen for leg 'stiffness' thought to be secondary to birth injury. Examination then revealed increased resistance to passive movement although power, tendon reflexes and plantar responses were normal. She had occasional jerking movements ofher legs soon after bginning baclofen but an electroencephalogram (EEG) in May 1984 was normal. The baclofen was slowly increased to 80 mg a day. Between mid 1986 and early 1987 she had four episodes of loss of consciousness and was admitted to a different hospital where she was noted to have nocturnal fits with associated raised serum prolactin and an abnormal EEG. She was prescribed phenytoin and the baclofen was continued.
In May 1987 when admitted under our care she had had three fits in 24 h and then developed status epilepticus. Her condition deteriorated and she had more than 200 fits in two weeks and required assisted respiration. During her admission the baclofen was slowly reduced over a period of 3 weeks and the fits were controlled with phenytoin and sodium valproate. Her brain CT scan was normal. From July 1987 the anticonvulsant drugs were gradually reduced so that by July 1988 she was taking no medication. She was still free of fits when last seen in March 1989.
Discussion
The evidence is strong that baclofen was an important and probably the only factor precipitating her fits. It is unlikely that she had a tendency to epilepsy related to a brain injury at birth as her EEGs were normal when she was taking a small dose ofbaclofen and when off all medication. She never had convulsions when not taking baclofen. Fits can be caused by rapid withdrawal of baclofen3, especially in patients known to be liable to epilepsy, although it has not been shown to have a deleterious effect in patients with epilepsy4.
Baclofen is structurally similar to the inhibitory neurotransmitter, GABA, and stimulates GABA receptors. GABAergic mechanisms are important in the pathogenesis of epilepsy5. There are two types of GABA receptor, A and B, both of which are found both pre and post-synaptically. Stimulation of GABA-A receptors causes an influx ofchloride ions which has the effect of inhibiting plarizion, stabilizin the membrane and hence reducing the chance of epilepsy. Baclofen acting on GABA-B receptors hyperpolarizes neurons, by increasing K+ conductance6. Baclofen also decreas Ca2e conductance and thereby diminishes synaptic release ofsome neurotranamitters. How these effects relate to a proconvulsive action of baclofen is not yet clear.
It is suggested that baclofen can cause epilepsy and should be withdrawn gradually from all patients who develop epilepsy while taking it. Case report A 75-year-old women presented with a 24 h history of lower abdominal pain and distension. She had atrial fibrillation associated with mitral stenosis, and had been on warfarin 6 mg daily for 9 years. There was no history of abdominal trauma. Clinically she appeared pale, but there were no signs of shock. Her abdomen was tense, distended, and generally tender. Haemoglobin on admission was 9.6 g/dl. White cell count was normal. International Normalied Ratio (INR) was greater than 10 (therapeutic range 24). Four hours following admission she developed bruising in the flanks and over the anterior abdominal wall, suggestive of retroperitoneal haemorrhage.
Vitamin K and fresh frozen plasma were given intravenously to correct her abnormal blood clotting. An abdominal ultrasound scan showed free fluid around the liver and spleen but the retroperitoneum was entirely clear. The peritoneal signs became more marked and subsequently an emergency laparotomy was performed. The findings were approximately 500 ml of free blood within the peritoneal cavity and a large haematoma within the small bowel mesentery. There was no evidence of retroperitoneal haemorrhage. The mesenteric vessels proximal to the haematoma were pulsatile but not those within or distal to it. Approximately 30 cm of related mid small bowel was severely congested and nonviable in places. Small bowel resection with primary anastomosis was performed and she made an uncomplicated recovery.
Histology of the resected specimen showed extensive mucosal, submucosal, and mesenteric haemorrhage. The cause of her over-anticoagulation remains obscure. She was not on any warfarin potentiating drugs and her liver fiuction was normal. She was re-stabilized on warfarin and allowed home. One month later she was re-admitted with an acute abdomen. INR was again greater than 10. Laparotomy revealed free blood and two loops of infarcted small bowel with perforation, associated with large isolated haematomas within the mesentery. Small bowel recion was performed and she made an uneventful recovery.
Histology of the resected bowel confirmed full thickness infarction. Anticoagulants were not re-instituted and she went home. Two months after discharge she died suddenly at home. Postmortem examination was not performed.
There has only been one previously reported case of spontaneous, isolated mesenteric haematoma occurring in a patient on oral anticoagulants3. The clinical presentation of mesenteric haematoma will vary according to the location and extent of bleeding. If intramural bleeding is severe it may lead to intestinal obstruction4 and there may be blood present in the stool, whereas predominant bleeding into the mesentery may produce a palpable abdominal mass. In this case, the end result was venous infarction of the bowel requiring urgent laparotomy and small bowel resection.
The non-specific presenting symptoms of abdominal pain, tenderness, bruising in the flanks, and possibly a mass palpable in the abdomen, loin or groin, may result in diagnostic confusion with spontaneous retroperitoneal haemorrhage. In the latter condition, the additional features of a compression neuropathy, usually affecting the femoral nerve, and a paralytic ileus are often present5. Hypovolaemic shock and sudden death may also occur6.
The diagnosis of these potentially lethal complications requires a high index of suspicion. Ultrasonography and CT scan are often helpful in the diagnosis of retroperitoneal haematoma, and their use is advocated in the diagnosis and subsequent follow up of mesenteric haematomas3. In this case, however, ultrasound scanning failed to detect the mesenteric haematoma but correctly excluded retroperitoneal haemorrhage.
The management of spontaneous mesenteric haematoma should initially be conservative and defective clotting corrected. Surgery is indicated if generalized peritonitis or intestinal obstruction develops. Retoeritoneal haemorrhage should be excluded prior to operation as in this condition surgery is normally reserved for those patients who develop life threatening complications such as acute renal failure, sepsis, or disseminated intravascular coagulation2.
